Friday, March 14, 2025
spot_img

Technip Energies publishes 2024 Annual Report

Technip Energies (PARIS:TE) (the “Company”), a global technology & engineering powerhouse leading in energy and decarbonization infrastructure, today published its 2024 Annual Report.

The Company filed its 2024 Annual Report with the Autoriteit Financiële Markten (AFM) in the Netherlands and the Autorité des marchés financiers (AMF) in France.

The 2024 Annual Report is available at https://investors.technipenergies.com/financial-information/results-center.

Technip Energies will hold its Annual General Meeting in Schiphol, the Netherlands on May 6, 2025. The convening notice, agenda and all related documents will be available at https://investors.technipenergies.com/events-presentations/agm on March 25, 2025.

About Technip Energies

Technip Energies is a global technology and engineering powerhouse. With leadership positions in LNG, hydrogen, ethylene, sustainable chemistry, and CO2 management, we are contributing to the development of critical markets such as energy, energy derivatives, decarbonization, and circularity. Our complementary business segments, Technology, Products and Services (TPS) and Project Delivery, turn innovation into scalable and industrial reality.

Through collaboration and excellence in execution, our 17,000+ employees across 34 countries are fully committed to bridging prosperity with sustainability for a world designed to last.

Technip Energies generated revenues of €6.9 billion in 2024 and is listed on Euronext Paris. The Company also has American Depositary Receipts trading over the counter.

For further information: www.ten.com

Contacts

Investor Relations Media Relations
Phillip Lindsay Jason Hyonne
Vice-President Investor Relations          Press Relations & Social Media Manager
Tel: +44 207 585 5051   Tel: +33 1 47 78 22 89
Email: Phillip Lindsay     Email: Jason Hyonne

 

Attachment

  • 2024 Annual Financial Report Availability Press Release_EN

Powered by SlickText.com

Hot this week

NORBIT – Awarded NOK 260 million orders

Trondheim, 14 March 2025: NORBIT today announces that segment...

Transaction in Own Shares

ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 14...

Idorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturia

Daridorexant, Idorsia’s dual orexin receptor antagonist, shows consistent efficacy...

Topics

NORBIT – Awarded NOK 260 million orders

Trondheim, 14 March 2025: NORBIT today announces that segment...

Transaction in Own Shares

ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 14...

Idorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturia

Daridorexant, Idorsia’s dual orexin receptor antagonist, shows consistent efficacy...

Parsons to Present at the Bank of America Global Industrials Conference

CHANTILLY, Va., March 13, 2025 (GLOBE NEWSWIRE)...
spot_img

Related Articles

Popular Categories

spot_img